In recent studies, these truncating mutations of PPM1D in mosaic form were found in the blood with higher frequency among patients with ovarian cancer or breast cancer than in the control group [5,12], suggesting a causal relationship between the mutations and the cancers. The gene discussed is PPM1D; the disease is breast carcinoma.